Active Labelers Run Date : Aug 28, 2019
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Market Cap Close ADV
Market Cap Close ADV 1598 67th Pctl $745,214,477.91 $23.96 225,966.94 801 33rd Pctl $199,581,478.89 $10.09 53,054.83 2399 Listing_ Revised Ticker_Symbol Security_Name Exchange Effective_Date Mkt Cap Close ADV Stratum Stratum AAC AAC Holdings, Inc. N 20160906 M M M M-M-M M-M-M Altisource Asset Management AAMC Corp A 20160906 L M L L-M-L L-M-L AAN Aarons Inc N 20160906 H H H H-H-H H-H-H AAV Advantage Oil & Gas Ltd N 20160906 H L M H-L-M H-M-M AB Alliance Bernstein Holding L P N 20160906 H M M H-M-M H-M-M ABG Asbury Automotive Group Inc N 20160906 H H H H-H-H H-H-H ABM ABM Industries Inc. N 20160906 H H H H-H-H H-H-H AC Associated Capital Group, Inc. N 20160906 H H L H-H-L H-H-L ACCO ACCO Brand Corp. N 20160906 H L H H-L-H H-L-H ACU Acme United A 20160906 L M L L-M-L L-M-L ACY AeroCentury Corp A 20160906 L L L L-L-L L-L-L ADK Adcare Health System A 20160906 L L L L-L-L L-L-L ADPT Adeptus Health Inc. N 20160906 M H H M-H-H M-H-H AE Adams Res Energy Inc A 20160906 L H L L-H-L L-H-L American Equity Inv Life Hldg AEL Co N 20160906 H M H H-M-H H-M-H AF Astoria Financial Corporation N 20160906 H M H H-M-H H-M-H AGM Fed Agricul Mtg Clc Non Voting N 20160906 M H M M-H-M M-H-M AGM A Fed Agricultural Mtg Cla Voting N 20160906 L H L L-H-L L-H-L AGRO Adecoagro S A N 20160906 H L H H-L-H H-L-H AGX Argan Inc N 20160906 M H M M-H-M M-H-M AHC A H Belo Corp N 20160906 L L L L-L-L L-L-L ASPEN Insurance Holding AHL Limited N 20160906 H H H H-H-H H-H-H AHS AMN Healthcare Services Inc. -
Ipo Analysis
IPO ANALYSIS Snap Research on potential upcoming IPOs from Hamilton Lane Bitcoin Investment Trust selected candidate companies. Visterra Braeburn Pharmaceuticals December, 2016 VentureDeal Snap Files S-1 Registration For $3 Billion IPO Quick Take Camera company Snap Inc. (Pending:SNAP) has filed its initial S-1 registration for a $3 billion IPO at an undisclosed valuation. Snap views the camera as the primary use of the mobile device and seeks to monetize its user base primarily through advertising. The company has a short history of rapidly growing revenues, which exceeded $400 million in 2016. Company Venice-based Snap was founded in 2012 by current CEO Evan Spiegel and current CTO Robert Murphy to initially provide users with a smartphone app that enabled them to post pictures that were automatically deleted after a brief time period. The company has since expanded its scope to include chat, video, media that does not become automatically deleted, and a camera integrated into sunglasses. Below is a brief company video on its recently introduced Spectacles product: (Source: Snap YouTube) Snap has raised in excess of $2.6 billion in several private financing rounds from numerous investors including top tier venture capital firms, corporate investors, private equity firms and government-owned investment enterprises. The company claims that 158 million people use its flagship Snapchat each day, creating over 2.5 billion 'Snaps'. Market and Competition Snap operates a largely advertising-driven business model, although it does sell its Spectacles product for $129 each. It seeks to provide advertisers with access to its user base, which has typically centered around a younger demographic, between the ages of 14-30. -
Fidelity® Total Market Index Fund
Quarterly Holdings Report for Fidelity® Total Market Index Fund May 31, 2021 STI-QTLY-0721 1.816022.116 Schedule of Investments May 31, 2021 (Unaudited) Showing Percentage of Net Assets Common Stocks – 99.3% Shares Value Shares Value COMMUNICATION SERVICES – 10.1% World Wrestling Entertainment, Inc. Class A (b) 76,178 $ 4,253,780 Diversified Telecommunication Services – 1.1% Zynga, Inc. (a) 1,573,367 17,055,298 Alaska Communication Systems Group, Inc. 95,774 $ 317,970 1,211,987,366 Anterix, Inc. (a) (b) 16,962 838,941 Interactive Media & Services – 5.6% AT&T, Inc. 11,060,871 325,521,434 Alphabet, Inc.: ATN International, Inc. 17,036 805,292 Class A (a) 466,301 1,099,001,512 Bandwidth, Inc. (a) (b) 34,033 4,025,764 Class C (a) 446,972 1,077,899,796 Cincinnati Bell, Inc. (a) 84,225 1,297,065 ANGI Homeservices, Inc. Class A (a) 120,975 1,715,426 Cogent Communications Group, Inc. (b) 66,520 5,028,912 Autoweb, Inc. (a) (b) 6,653 19,028 Consolidated Communications Holdings, Inc. (a) 110,609 1,035,300 Bumble, Inc. 77,109 3,679,641 Globalstar, Inc. (a) (b) 1,067,098 1,707,357 CarGurus, Inc. Class A (a) 136,717 3,858,154 IDT Corp. Class B (a) (b) 31,682 914,343 Cars.com, Inc. (a) 110,752 1,618,087 Iridium Communications, Inc. (a) 186,035 7,108,397 DHI Group, Inc. (a) (b) 99,689 319,005 Liberty Global PLC: Eventbrite, Inc. (a) 114,588 2,326,136 Class A (a) 196,087 5,355,136 EverQuote, Inc. -
References Used in Algorithms for the Treatment of Persons with Crohn’S Disease
REFERENCES USED IN ALGORITHMS FOR THE TREATMENT OF PERSONS WITH CROHN’S DISEASE 1. AA Pharma Inc: Winpred (prednisone). In: CA Product Monograph. Vaughan, ON; 2018. 2. AbbVie Corporation: Humira (adalimumab). In: CA Product Monograph. St Laurent, QC; 2019. 3. AbbVie Inc: Humira (adalimumab). In: US Product Monograph. North Chicago, IL; 2020. 4. Amgen Canada Inc: Avsola (infliximab). In: CA Product Monograph. Mississauga, ON; 2020. 5. Amgen Inc: Amjevita (adalimumab-atto). In: US Product Monograph. Thousand Oaks, CA; 2019. 6. Amgen Inc: Avsola (infliximab-axxq). In: US Product Monograph. Thousand Oaks, CA; 2019. 7. Antares Pharma Inc: Methotrexate. In: FDA Product Monograph. Ewing, NJ; 2019. 8. Apotex Inc: Methotrexate. In: CA Product Monograph. Toronto, ON; 2019. 9. Asada A, Nishida A, Shioya M, Imaeda H, Inatomi O, Bamba S, Kito K, Sugimoto M, Andoh A: NUDT15 R139C-related thiopurine leukocytopenia is mediated by 6-thioguanine nucleotide-independent mechanism in Japanese patients with inflammatory bowel disease. Journal of gastroenterology 2016, 51(1):22-29. 10. Aspen Pharmacare Canada Inc: Imuran (azathioprine). In: CA Product Monograph. Oakville, ON; 2019. 11. Biogen Canada Inc: Tysabri (natalizumab). In: CA Product Monograph. Mississauga, ON; 2017. 12. Biogen Idec Inc: Tysabri (natalizumab). In: US Product Monograph. Cambridge, MA; 2019. 13. Birdwell KA, Decker B, Barbarino JM, Peterson JF, Stein CM, Sadee W, Wang D, Vinks AA, He Y, Swen JJ et al: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing. Clinical pharmacology and therapeutics 2015, 98(1):19-24. 14. Boehringer Ingelheim Pharmaceuticals Inc: Cyltezo (adalimumab-adbm). In: US Product Monograph. Ridgefield, CT; 2019. -
Long Term Care Pharmacy
2201812 Long Term Care Pharmacy Long-Term Care Pharmacy of charge as value-added services. They include: Our mission is to provide our long-term care pharmacy › Access to our staff of eight in-house clinical experts. members with the tools they need to maximize savings › CE credits through a monthly teleconference program, while enhancing the quality of care they provide. In 1993, in-person programming, and written education Innovatix began as a pharmacy-focused GPO, and over programs. the years has become the industry leader with over 15,000 › Care Solutions manuals that serve as management unique NDCs and a number of pharmacy support products guides for specific diseases and conditions. and services. As a wholly-owned subsidiary of Premier, › Contract Advantage tools that help members save by Innovatix also offers members access to one of the most providing contracted alternatives to higher-priced non- robust, competitive equipment, supply, and service contracted drugs. portfolios available. › Updated clinical news and resources. GPO Support Services Multi-Tiered Customer Support At Innovatix, we realize that securing best-in-class pricing Innovatix members receive ongoing support from a is only half of the equation. That’s why we’ve developed team of experienced professionals who are committed a suite of tools and services designed to ensure our to delivering exceptional value and complete member members receive discounted pricing and have sufficient satisfaction. Our customer care teams work with each data to make informed purchasing decisions. Our tools member individually, analyzing data to identify purchasing and services include: needs and goals. Our objective is to secure the greatest › Electronic contract attachment technology designed to value for each of our members. -
Pharmaceutical Company Contact Information (PDF)
Pharmaceutical Company Contact Information - Rebate Filing - as of June 2018 Labeler Name Invoice Contact Phone Extension 00002 LILLY USA, LLC LISA NORTON (317) 276-2000 00003 ER SQUIBB AND SONS INC. LYNN LEWIS (609) 897-4731 00004 GENENTECH CONTRACT ADMINISTRATION (650) 866-2666 00005 LEDERLE LABORATORIES DAN MAGUIRE (484) 563-5097 00006 MERCK & CO., INC. DOUG BICKFORD (215) 652-0671 00007 SMITHKLINE BEECHAM DAVID BUCKLEY (215) 751-5690 00008 WYETH LABORATORIES JENNIFER WOOTEN (901) 215-1883 00009 PHARMACIA AND UPJOHN COMPANY/PFIZER JENNIFER WOOTEN (901) 215-1883 00013 PHARMACIA AND UPJOHN COMPANY NICHOLAS CHRISTODOULOU (336) 291-1053 00014 G. D. SEARLE & CO. CINDY MCDONALD (847) 581-5726 00015 MEAD JOHNSON AND COMPANY LYNN LEWIS (609) 897-4731 00016 PHARMACIA INC. BARBARA WINGET (908) 901-7254 00023 ALLERGAN INC SHOBHANA MINAWALA (714) 246-6205 00024 SANOFI WINTHROP PHARMACEUTICALS LAURIE DUNLAP, ADMIN., GOVT. OPERATIONS (212) 551-4198 00025 PHARMACIA CORPORATION NICHOLAS CHRISTODOULOU (336) 291-1053 00026 BAYER CORPORATION PHARMACEUTICAL DIV. LINDA WOLCHESKI (203) 812-6372 00028 NOVARTIS PHARMACEUTICALS (862) 778-8094 00029 SMITHKLINE BEECHAM DAVID BUCKLEY (215) 751-5690 00031 A. H. ROBINS COMPANY DAN MAGUIRE (610) 902-3222 00032 SOLVAY PHARMACEUTICALS STACEY LENOX (847) 937-3979 00033 SYNTEX LABORATORIES, INC. JANICE BRENNAN (973) 562-3494 00034 THE PURDUE FREDERICK COMPANY JUNE STOWE (203) 899-8035 00037 CARTER-WALLACE, INC. JAY R BRENNAN (609) 655-6163 00038 ASTRAZENECA LP DAVID WRIGHT (302) 886-2268 7820 00039 AVENTIS PHARMACEUTICALS (908) 981-7461 00043 NOVARTIS CONSUMER HEALTH, INC. EDWARD D. COLLINS (973) 781-6191 00044 KNOLL LABORATORIES DEBRA DEYOUNG (847) 937-4372 00045 MCNEIL PHARMACEUTICAL (908) 218-6777 00046 AYERST LABORATORIES (901) 215-1473 00047 WARNER CHILCOTT LABORATORIES LISA KAROLCHYK (973) 442-3262 00048 KNOLL PHARMACEUTICAL COMPANY DEBRA DEYOUNG (847) 937-4372 00049 ROERIG NICHOLAS CHRISTODOULOU (336) 291-1053 00051 UNIMED PHARMACEUTICALS, INC STACY LENOX (847) 937-3979 00052 ORGANON, USA, INC. -
Rebateable Manufacturers
Rebateable Labelers – July 2021 Manufacturers are responsible for updating their eligible drugs and pricing with CMS. Montana Healthcare Programs will not pay for an NDC not updated with CMS. Note: Some manufacturers on this list may have some NDCs that are covered and others that are not. Manufacturer ID Manufacturer Name 00002 ELI LILLY AND COMPANY 00003 E.R. SQUIBB & SONS, LLC. 00004 HOFFMANN-LA ROCHE 00006 MERCK & CO., INC. 00007 GLAXOSMITHKLINE 00008 WYETH PHARMACEUTICALS LLC, 00009 PHARMACIA AND UPJOHN COMPANY LLC 00013 PFIZER LABORATORIES DIV PFIZER INC 00015 MEAD JOHNSON AND COMPANY 00023 ALLERGAN INC 00024 SANOFI-AVENTIS, US LLC 00025 PFIZER LABORATORIES DIV PFIZER INC 00026 BAYER HEALTHCARE LLC 00032 ABBVIE INC. 00037 MEDA PHARMACEUTICALS, INC. 00039 SANOFI-AVENTIS, US LLC 00046 WYETH PHARMACEUTICALS INC. 00049 ROERIG 00051 ABBVIE INC 00052 ORGANON USA INC. 00053 CSL BEHRING L.L.C. 00054 HIKMA PHARMACEUTICAL USA, INC. 00056 BRISTOL-MYERS SQUIBB PHARMA CO. 00065 ALCON LABORATORIES, INC. 00068 AVENTIS PHARMACEUTICALS 00069 PFIZER LABORATORIES DIV PFIZER INC 00071 PARKE-DAVIS DIV OF PFIZER 00074 ABBVIE INC 00075 AVENTIS PHARMACEUTICALS, INC. 00078 NOVARTIS 00085 SCHERING CORPORATION 00087 BRISTOL-MYERS SQUIBB COMPANY 00088 AVENTIS PHARMACEUTICALS 00093 TEVA PHARMACEUTICALS USA, INC. 00095 BAUSCH HEALTH US, LLC Page 1 of 19 Manufacturer ID Manufacturer Name 00096 PERSON & COVEY, INC. 00113 L. PERRIGO COMPANY 00115 IMPAX GENERICS 00116 XTTRIUM LABORATORIES, INC. 00121 PHARMACEUTICAL ASSOCIATES, INC. 00131 UCB, INC. 00132 C B FLEET COMPANY INC 00143 HIKMA PHARMACEUTICAL USA, INC. 00145 STIEFEL LABORATORIES, INC, 00168 E FOUGERA AND CO. 00169 NOVO NORDISK, INC. 00172 TEVA PHARMACEUTICALS USA, INC 00173 GLAXOSMITHKLINE 00178 MISSION PHARMACAL COMPANY 00185 EON LABS, INC. -
Convention Exhibitors and Sponsors—October 2007
CONVENTION EXHIBITORS /alert Marketing Drug Enforcement Innovation Outcomes Pharmaceutical Abbott Administration Innovatix HealthCare Abbott Diabetes Care Drug Topics InterCure Owen Mumford Acorda Therapeutics Duramed Pharmaceuticals, Inc. Janssen L.P. PAAS National Adams Respiratory Therapeutics Eagle Health Supplies, Inc. Jascorp Pacific Pharmacy Computers Aetrex Worldwide, Inc. ECRS Kelli’s Gift Shop Suppliers Package Express Center, Inc. AIMSCO/Delta Hi-Tech, Inc. EISAI KeyCentrix Inc. Paddock Laboratories, Inc. Alpharma Eli Lilly & Company Kinray Inc. Pakor Inc. American Lifeline Emdeon Business Services Kirby Lester, LLC Parata Systems American Pharmacists Emporos Systems Lexi-Comp ParMed Pharmaceuticals Association Endo Pharmaceuticals Inc. Liberty Photo Products Partners in Pharmacy American Society of EPIC Pharmacies Inc. Life Line Screening PBA /TrueCare Pharmacies Consultant Pharmacists eRx Network, LLC Life-File LLC PDQ Communications Inc. AmerisourceBergen ETHEX Corporation LifeScan Inc. PDX-RX.com-PCI-FDS Corporation EXP Pharmaceutical Managed Health Care Pharmacist e-link Anda Inc. Services Corp. Associates Inc. Pharmacists Mutual Companies Apotex Corporation FDS, Inc. Mason Vitamins Inc. Pharmacists OnLine Apothecary Products Inc. Federation of Pharmacy Masters Pharmaceutical, a Pharmacy Choice, Inc. Apothecary Rx Networks Div. of DBS Trading Inc. Pharmacy Consulting Associates Associated Pharmacies, Inc. Fillmaster Systems LLC Maxim Staffing Solutions Pharmacy Development Services Astellas Pharma US Inc. First DataBank McKesson Pharmacy First/Wholesale AstraZeneca Flavorx McQueary Brothers Drug Co. Alliance LLC Ateb, Inc. G & W Laboratories, Inc. Meadowbrook Insurance Group Pharmacy Times Auburn Pharmaceutical G+M North America, Inc. Medical Matrix LP Pharmex, a Div of Time Auxilium Pharmaceuticals, Inc. Gallipot Inc. Medicine Shoppe Med Labeling Bayer Healthcare GeriMed/Rx Med/IV Med International, Inc. Pill Box, The Pharmaceuticals Gifts for Medical Professionals Medisca Inc. -
Valuation Multiples by Industry
Valuation Multiples by Industry https://www.eval.tech SIC Sector: (2000-3999) Manufacturing Report Date: 30 June 2021 Country: United States of America (U.S.A.) Industry Valuation Multiples The table below provides a summary of median industry enterprise value (EV) valuation multiples, as at the Report Date. The data is grouped by industry SIC code: EV Multiple Max # Rev EBITDA EBIT TotAss TanAss Food And Kindred Products (2000) 14 2.27 13.23 16.02 1.94 4.15 Canned, Frozen & Preservd Fruit, Veg & Food Specialties 6 3.66 22.55 32.27 2.10 3.51 (2030) Grain Mill Products (2040) 5 2.14 12.88 18.38 1.48 3.04 Sugar & Confectionery Products (2060) 5 2.98 - - 1.97 2.66 Beverages (2080) 12 4.35 19.33 23.19 2.33 4.47 Malt Beverages (2082) 5 1.97 19.88 - - 1.83 Bottled & Canned Soft Drinks & Carbonated Waters (2086) 9 1.84 12.71 12.91 1.47 3.22 Miscellaneous Food Preparations & Kindred Products (2090) 5 3.89 - - 1.87 7.19 Cigarettes (2111) 5 3.33 10.90 11.89 2.30 3.62 Apparel & Other Finishd Prods Of Fabrics & Similar Matl 12 2.26 10.52 12.04 1.56 2.08 (2300) Men’S & Boys’ Furnishgs, Work Clothg, & Allied Garments 7 2.18 27.71 34.50 2.32 2.80 (2320) Household Furniture (2510) 12 0.96 13.72 16.14 1.15 1.68 Paper Mills (2621) 8 1.10 8.36 12.68 0.79 0.92 Newspapers: Publishing Or Publishing & Printing (2711) 5 0.90 22.92 81.50 0.84 1.49 Chemicals & Allied Products (2800) 10 1.85 16.67 17.68 1.58 2.17 Industrial Inorganic Chemicals (2810) 10 1.58 11.32 20.09 0.90 0.92 Plastic Materials, Synth Resins & Nonvulcan Elastomers 12 2.00 15.35 22.76 1.24 2.25 -
MANUFACTURERS with CMS AGREEMENTS AS of 5-14-21 Labeler Code Labeler Name Program End Date 00002 ELI LILLY and COMPANY 00003 E.R
MANUFACTURERS WITH CMS AGREEMENTS AS OF 5-14-21 Labeler Code Labeler Name Program End Date 00002 ELI LILLY AND COMPANY 00003 E.R. SQUIBB & SONS, LLC. 00004 HOFFMANN-LA ROCHE 00006 MERCK & CO., INC. 00007 GLAXOSMITHKLINE 00008 WYETH PHARMACEUTICALS LLC, 00009 PHARMACIA AND UPJOHN COMPANY LLC 00013 PFIZER LABORATORIES DIV PFIZER INC 00015 MEAD JOHNSON AND COMPANY 00023 ALLERGAN INC 00024 SANOFI-AVENTIS, US LLC 00025 PFIZER LABORATORIES DIV PFIZER INC 00026 BAYER HEALTHCARE LLC 00032 ABBVIE INC. 00037 MEDA PHARMACEUTICALS, INC. 00039 SANOFI-AVENTIS, US LLC 00046 WYETH PHARMACEUTICALS INC. 00049 ROERIG 00051 ABBVIE INC 00052 ORGANON USA INC. 00053 CSL BEHRING L.L.C. 00054 HIKMA PHARMACEUTICAL USA, INC. 00056 BRISTOL-MYERS SQUIBB PHARMA CO. 00065 ALCON LABORATORIES, INC. 00068 AVENTIS PHARMACEUTICALS 00069 PFIZER LABORATORIES DIV PFIZER INC 00071 PARKE-DAVIS DIV OF PFIZER 00074 ABBVIE INC 00075 AVENTIS PHARMACEUTICALS, INC. 00078 NOVARTIS 00085 SCHERING CORPORATION 00087 BRISTOL-MYERS SQUIBB COMPANY 00088 AVENTIS PHARMACEUTICALS 00093 TEVA PHARMACEUTICALS USA, INC. 00095 BAUSCH HEALTH US, LLC 00096 PERSON & COVEY, INC. 00113 L. PERRIGO COMPANY 00115 IMPAX GENERICS 00116 XTTRIUM LABORATORIES, INC. 00121 PHARMACEUTICAL ASSOCIATES, INC. 00131 UCB, INC. 00132 C B FLEET COMPANY INC 00143 HIKMA PHARMACEUTICAL USA, INC. 00145 STIEFEL LABORATORIES, INC, 00168 E FOUGERA AND CO. 00169 NOVO NORDISK, INC. 00172 TEVA PHARMACEUTICALS USA, INC Labeler Code Labeler Name Program End Date 00173 GLAXOSMITHKLINE 00178 MISSION PHARMACAL COMPANY 00185 EON LABS, INC. 00186 ASTRAZENECA PHARMACEUTICALS LP 00187 BAUSCH HEALTH US, LLC. 00206 WYETH PHARMACEUTICALS LLC, 00224 KONSYL PHARMACEUTICALS, INC. 00225 B. F. ASCHER AND COMPANY, INC. 00228 ACTAVIS PHARMA, INC. -
Auslaendische-Aktien-2020.Pdf
Verzeichnis der von der Kursliste der eidg. Steuerverwaltung per 31.12.2020 abweichenden Steuerwerte für die Staatssteuerveranlagung 2020 gilt nur für natürliche Personen mit Domizil im Kanton Basel-Landschaft Steuerwert 31.12.2020 Val. Nr. Titelbezeichnung Titelart in CHF Ausländische Aktien 24582375 ASHTROM GROUP LTD. Namenaktie 15.80 761515 ASICS Corporation Namenaktie 11.50 19531091 ASML Holding NV Inhaberaktie 267.60 828998 AT & S Austria Technologie & Systemtechnik AG Inhaberaktie 21.85 3073309 Aalberts N.V. Inhaberaktie 34.15 903037 Abbott Laboratories Stammaktie 70.30 522413 Abercrombie & Fitch Co. Namenaktie 17.20 903092 Abiomed Inc Namenaktie 143.30 1532828 Acacia Research Corporation Namenaktie 1.75 1184425 Acadia Pharmaceuticals Inc. Namenaktie 23.65 10478724 Accenture plc Namenaktie 160.10 485822 Accor S.A. Inhaberaktie 25.85 812970 Ackermans & van Haaren NV Namenaktie 109.25 3971431 Activision Blizzard, Inc. Namenaktie 47.50 857018 Adacel Technologies Limited Namenaktie 0.52 11730015 Adidas AG Namenaktie 193.60 34149058 Adient plc Namenaktie 15.35 903472 Adobe Inc. Namenaktie 221.05 36416063 Adomos Stammaktie 0.21 36832098 Adtalem Global Education Inc. Namenaktie 15.00 1331600 Advance Auto Parts, Inc. Namenaktie 78.00 903491 Advanced Micro Devices, Inc. Namenaktie 40.55 1027712 Advantech Co., Ltd. Namenaktie 9.55 42119868 Adyen N.V. Stammaktie 1030.20 2736001 Aedifica SA Inhaberaktie 105.85 587479 Aeroflot Namenaktie 0.77 28742001 Aeroporto Guglielmo Marconi di Bologna S.p.A. Namenaktie 8.85 903835 Aflac Incorporated Namenaktie 37.30 36293710 Afterpay Limited Namenaktie 40.25 748779 Agfa-Gevaert N.V. Inhaberaktie 2.15 901692 Agilent Technologies, Inc. Namenaktie 63.50 676894 Agnico Eagle Mines Limited Namenaktie 42.90 42430644 Ahlers AG Namenaktie 0.79 20029778 Ahlstrom-Munksjo Oyj Namenaktie 18.05 18564252 Aimia Inc. -
[ Emc-Lusinnufll'lergcrta'rgets
US 20070255633Al (19) United States (12) Patent Application Publication (10) Pub. N0.: US 2007/0255633 A1 Kridel (43) Pub. Date: NOV. 1, 2007 (54) SYSTEMS AND METHODS FOR INVESTING (52) US. Cl. ....................................................... .. 705/35 (76) Inventor: FIVJigiam J. Kridel, New York, NY (57) ABSTRACT The present invention discloses systems and methods for Correspondence Address? creating and managing ?nancial instruments and indexes PAUL’ HASTINGS’ JANOFSKY & WALKER comprised of securities for companies in subsectors of the LLP economy. These ?nancial instruments alloW investment in R0' BOX 919092 subsectors of the economy Will still being able to minimize SAN DIEGO CA 92191-9092 ’ risk by diversi?cation. The indexes serve as benchmarks for (21) App1_ NO; 11/465,768 companies in the subsectors of the economy. A procedure may be used to identify the securities to include in the (22) Filed: Allg- 18, 2006 ?nancial instruments. This procedure may include (a) iden _ _ tifying securities for companies in a sector of the economy; Related U's‘ Apphcatlon Data (b) limiting the identi?ed securities to those for companies (60) Provisional application No. 60/778,492, ?led on Mar. in a SubSeCIOr Of the SBCIOI‘ Of the economy; (0) applying 1, 2006. focus rules to further limit the identi?ed securities to those _ _ _ _ for companies Who are focused in the subsector of the Pubhcatlon Classl?catlon economy; and (d) limiting the securities included in the (51) Int, Cl, ?nancial instrument or index to those that satisfy other G06Q 40/00 (2006.01) objective criteria. ETF RULE. SET->| APPLICATION’ ' "1 _.